Send the following on WhatsApp
Continue to ChatAvalon's latest biotech closes $58M round as it pursues treatments for autoimmune brain conditions https://invesbrain.com/avalons-latest-biotech-closes-58m-round-as-it-pursues-treatments-for-autoimmune-brain-conditions/